© 2022 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Conatus Pharmaceuticals

Emricasan Proves a Disappointment as NASH Treatment

Nevertheless, researchers are hoping to learn more from the study of the caspase inhibitor among people with non-alcoholic steatohepatitis.

When Will We See Drug Treatments for NASH Fibrosis?

Currently, there are no pharmacological treatments for liver fibrosis related to non-alcoholic steatohepatitis.

Yet Again, Emricasan Yields No Benefit for Those With NASH

Conatus Pharmaceuticals’ study of emricasan for non-alcoholic steatohepatitis found the drug had no significant impact.
Advertisement

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.